Skip to content

Shenfu injection in the treatment of cancer-related fatigue

Shenfu injection in the treatment of cancer-related fatigue

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004776
Enrollment
Unknown
Registered
2014-05-31
Start date
2014-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer-related fatigue

Interventions

experimental group:Shenfu injection
control group:blank

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Meets all of the following items could be include: 1. pathology diagnosed cancer patients; 2. standard edition 10 conforms to the international classification of diseases (ICD - 10) CFR western medicine diagnostic criteria; 3. in the diagnosis of syndrome of blood stasis of TCM; 4. aged between 18 to 75 years old, male or female; 5. voluntary drug treatment, and sign the informed consent. The informed consent process in conformity with the relevant provisions of the GCP.

Exclusion criteria

Exclusion criteria: Have any of the following items shall not be included: 1. the ongoing radiotherapy or chemotherapy patients; 2. severe pain, severe anemia, lead to fatigue of cancer patients; 3. allergic constitution, or for a variety of drug allergy, or known allergy to this drug ingredients; 4. fatigue caused by other systemic diseases, drugs; 5. pregnancy and nursing mothers; 6. has used a similar other drugs for the treatment of the disease. Once patients mentally or legal disability. Being the researchers think that there is not suitable for selected patients.

Design outcomes

Primary

MeasureTime frame
Cancer-related fatigue;

Secondary

MeasureTime frame
Signs and symptoms in TCM;Quality of Life-Liver Cancer;depression scale;

Countries

China

Contacts

Public ContactHu Xia
583631285@qq.com+86 15982831178

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026